RIDMAL TABLETS 9’S

Ridmal is a combination medication that contains Dihydroartemisinin (40 mg) and Piperaquine Phosphate (320 mg). It is primarily used for the treatment of uncomplicated malaria caused by Plasmodium falciparum, the most common and severe malaria parasite. Dihydroartemisinin is an artemisinin derivative that acts quickly to reduce the number of malaria parasites in the bloodstream, while Piperaquine is an antimalarial that helps to eliminate the remaining parasites and prevent relapse.

This combination therapy is effective in reducing the risk of developing drug resistance, as it utilizes two different mechanisms of action. Ridmal is typically administered in a short course, often over three days, and is suitable for both adults and children. It is important to use this medication under the guidance of a healthcare professional to ensure proper dosing and to monitor for any potential side effects.